Abstract
Introduction

Analytical method validation
As per ICH Building up documented evidence, which gives degree of proof that a particular activity will deliver a desired procedure or item meeting its determined specs and quality characters [1, 2] .
Objectives of validation
The varying nature of the inequality between the analytical development laboratory and q.c lab is a good reason for validation program. This study includes 1. Linearity 2. Accuracy 3. Precision 4. LOD 5. LOQ 6. Robustness 7. System suitability 8. Stability criteria.
Accuracy
The values obtained by % mean recovery. The test results acquired by the method to the genuine value (concentration) of the analyte by recreate examination of tests containing known measure of analyte across its range.
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The identification limit is the lower amount of specimen which can be identified but not really quantitated as a correct value.
Limit of Quantification (LOQ)
The LOQ is the lower measure of analyte in a specimen which is quantitatively decided with appropriate accuracy and precision.
Robustness
It is characterized as a measure of its capacity to stay unaffected by little but little variation in technique provide a sign of its indication during its usage.
System Suitability Testing
The parameters, includes, Resolution (Rs), Tailing factor, k and/or α, Plate number (N), and (%RSD) of peak height or peak area for continuous injections (Table 1) 
Selection of initial conditions for method development
Determination of solubility of drug solubility
Taken small amount of sample and dissolved it in various solvents and the solubility of drugs.
Selection of chromatographic methods
The proper selection of methods relies on the idea of the sample its mol wt and stability. The drugs selected are polar, ionic and hence Reversed phase chromatography was selected.
Drug Profile
Drug description of Metoprolol and Telmisartan is summarised in Tables 2 and 3 . Taken small amount of sample and dissolved it in various solvents and the solubility of drugs.
Selection of chromatographic methods
The proper selection of methods relies on the idea of the sample its mol wt and stability. The drugs selected are polar, ionic and hence Reversed phase chromatography was selected (Table 4) .
Analytical Method Validation Validation
Building up documented evidence, which gives a high level of affirmation that a action will reliably create a desired outcome or product meeting its predetermined details and quality attributes [3] [4] [5] [6] .
Validation parameters
• Accuracy
Accuracy
Procedure
Inject the Three injections of individual concentrations (50%, 100%, 150%) were made under the optimized conditions. Record and measure the peak responses. Calculate the VOL found, and VOL added for Telmisartan & Metoprolol and calculate each recovery and mean recovery values.
Acceptance criteria
The % for each level should be B/W 98.1 to 102.1 %
Precision
The standard solution was infused for 5 times and measure the area for each of the 5 infusions in HPLC. The %RSD was observed to be within the limits.
Acceptance criteria
The %RSD for five std injection results should not be>2% 
Procedure Day 1:
The standard solution was infused for 5 times and measure the area for each of the five infusions in HPLC.
The %RSD for the area of five copy infusions was seen to be inside the limits.
Day 2:
The standard solution was infused for 5 times and measure the area for each of the five infusions in HPLC was in limit
Acceptance criteria
The % RSD of 5 different sample solutions should not >2%. Table 4 : Method development trials parameters and optimized parameters.
Linearity Procedure
Inject each preparation (10, 20, 30, 40 , 50 ppm of drug) into the system and measure the peak area. Plot a graph of peak area vs concentration (on X-axis concentration and on Y-axis Peak area) and calculate the correlation coefficient [7] [8] [9] [10] [11] [12] .
Acceptance criteria
Correlation coefficient should be not <0.999.
Limit of Quantification
LOQ is characteristic should be detected mainly impurities, forced degradation studies .it can be 
Robustness
The analysis was performed in different conditions to find the variability of test results. The following conditions are checked for variation of results.
Effect of variation of flow
Sample was analysed at 0.9 mL/min and 1.1 mL/min instead of 1mL/min, remaining conditions are same. The 20 µL of the above sample was injected twice.
Effect of variation of mobile phase organic composition
Sample was analyzed by variation of mobile phase i.e. Methanol: Phosphate buffer 3.6 pH: ACN was taken in the ratio and 54:46, 63:37 instead of 58:42, remaining conditions are same. 20µl of the above sample was injected twice and chromatograms were recorded. [13] [14] [15] [16] [17] [18] .
Results and Discussion
Method development
The present investigation was to develop a new method and validation by RP-HPLC (Figures 1-6 ) (Tables 5-10 ). 
Observation
In this trial it shows less plate count and no good separation of two peaks in the chromatogram. So, it's required more trials to obtain good peaks. 
In this trail the peak shape is improper and more plate count. So, it's required more trials to obtain good peaks. 
In this trail the peak doesn't shows more difference between two drugs. So, it's required more trials to obtain good peaks. 
From the above trail we concluded that all the system suitability parameters are in limits. Hence the method was optimized.
Optimized Chromatogram (Sample) Figure 6 : Optimized Chromatogram (Sample). 
Acceptance criteria
• 1Theoretical plates must be not <2000
• Tailing factor must be not <2.
Method Validation Accuracy
Accuracy at different concentrations (50%, 100%, and 150%) was prepared and the % recovery was calculated.
The Accuracy studies were shown as % recovery for In the precision study %RSD was found to be less than 2%. For Telmisartan %RSD is 0.24 and Metoprolol % RSD is 0.81 which indicates that the system has good reproducibility. For precision studies 5 duplicate injections of Telmisartan and Metoprolol was performed. % RSD was determined for peak area of Telmisartan and Metoprolol. The acceptance limit should be not >2% and the results were found to be within the acceptance limits.
Hence method is precise (Tables 13 and 14) .
Intermediate precision Day 1:
In the Day1 precision study for Telmisartan and Metoprolol's %RSD was 0.01817 & 0.758 respectively and found to be less than 2% which indicates that the system has good reproducibility. For intermediate precision studies 6 duplicate injections of Telmisartan and Metoprolol was performed and %RSD was determined for peak area of Telmisartan and Metoprolol. The limit should be not >2% and results were found to be within the limit.
Day 2:
In the Day 2 precision study %RSD was found to be less than 2%. For Telmisartan and Metoprolol % SD is 0.78 & 0.87 respectively which indicates that the system has good reproducibility. For intermediate precision studies 6 injections of Telmisartan and Metoprolol was performed and % RSD was determined for peak area of Telmisartan and Metoprolol. The acceptance limit should be not >2% and results were found to be within the limit (Tables 15 and 16 ).. The linearity range was found to be 10-50 µg/ml for Telmisartan & Metoprolol. Calibration curve was plotted and correlation co-efficient for the drug found to be 0.999 & 0.996 are within limit (Figures 7 and 8 ) (Tables 17 and  18 ).
Limit of detection (LOD) Telmisartan
From the above, the LOD values of Telmisartan and Metoprolol were found to be 1.25 µg/ml & 1.69 µg/ml respectively. The LOQ values were found to be 3.817 µg/ml & 5.12 µg/ml respectively. Thus, the method developed was found to be sensitive. 
Acceptance criteria
The tailing factor should be < 2.0 and the number of theoretical plates (N) should be >2000.
Summary and Conclusion
RP-HPLC technique was produced for estimation of Telmisartan and Metoprolol in its mass and pharmaceutical dosage form. Chromatographic separation was performed on X Bridge C18 (4.6×250mm) 5µ, with mobile phase including mixture Methanol: Water balanced the pH 3.5 with OPA (58:42% v/v), at the stream rate 1ml/min. The recognition was carried at 224 nm (Table 25 ).
The proposed RP-HPLC technique was observed to be exact, particular, precise, quick and economical for estimation of Telmisartan and Metoprolol in its bulk and pharmaceutical dosage form. The sample recoveries in all formulations were in great in terms with their Label Claims and this technique can be utilized for routine analysis. It can be connected for routine analysis in labs and is reasonable for the quality control of the crude materials, formulations, disintegration studies can be utilized for bioequivalence studies for the same formulation. 
